The Lancet Respiratory Medicine in conversation with
Editors at The Lancet Respiratory Medicine, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.
A monthly audio companion to the journal, this podcast covers a broad range of topics, from long COIVD outcomes to tobacco control, the management of uncontrolled asthma to intensive care medicine, and more.
Podcasting since 2012 • 156 episodes
The Lancet Respiratory Medicine in conversation with
Latest Episodes
Sandeep Sahay and Franck Rahaghi on future treatment paradigms in pulmonary arterial hypertension
Dr Sandeep Sahay and Professor Franck Rahaghi discuss their Personal View on future treatment paradigms in pulmonary arterial hypertension.
•
14:53
Sergio Harari sul trattamento della linfangioleiomiomatosi (LAM) (in Italian)
Il Professor Sergio Harari commenta i risultati di un trial clinico di fase 2 volto a valutare l’attivita’ e la sicurezza del farmaco nintedanib come trattamento in pazienti affetti da linfangioleiomiomatosi (LAM).
•
10:40
Sergio Harari on the treatment of lymphangioleiomyomatosis (LAM)
Professor Sergio Harari joins us to discuss the results of a phase 2 clinical trial evaluating activity and safety of nintedanib in people with lymphangioleiomyomatosis (LAM).
•
10:26
Robert Kullberg on empirical antibiotics for Sepsis
Dr Robert Kullberg joins us to discuss his Viewpoint on empiric antibiotic therapy for sepsis and the importance of reducing unnecessary use of anti-anaerobic antibiotics.Read the full article:
•
12:06
Heather Zar on early-life RSV disease and long-term respiratory health
Professor Heather Zar joins The Lancet Respiratory Medicine to discuss early-life RSV disease and long-term respiratory health. This topic will be covered in one of four Series papers in a cross-journal Series with The Lancet....
•
19:07